Claro Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,920
| Closed | -$72.8K | – | 417 |
|
|
2023
Q3 | $72.8K | Sell |
10,920
-186
| -2% | -$1.24K | 0.02% | 366 |
|
|
2023
Q2 | $101K | Sell |
11,106
-214
| -2% | -$1.94K | 0.03% | 367 |
|
|
2023
Q1 | $82.3K | Sell |
11,320
-500
| -4% | -$3.64K | 0.02% | 346 |
|
|
2022
Q4 | $86.2K | Sell |
11,820
-4,100
| -26% | -$29.9K | 0.03% | 310 |
|
|
2022
Q3 | $108K | Hold |
15,920
| – | – | 0.04% | 269 |
|
|
2022
Q2 | $108K | Sell |
15,920
-7,380
| -32% | -$50.1K | 0.04% | 268 |
|
|
2022
Q1 | $130K | Hold |
23,300
| – | – | 0.05% | 275 |
|
|
2021
Q4 | $130K | Buy |
23,300
+8,000
| +52% | +$44.6K | 0.05% | 275 |
|
|
2021
Q3 | $118K | Sell |
15,300
-550
| -3% | -$4.24K | 0.05% | 248 |
|
|
2021
Q2 | $163K | Buy |
15,850
+450
| +3% | +$4.63K | 0.07% | 227 |
|
|
2021
Q1 | $162K | Buy |
+15,400
| New | +$162K | 0.08% | 209 |
|